Michael C. Nivens

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

Michael E. Wechsler, Marcella Ruddy, Ian Pavord et al. · New England Journal of Medicine · 2021 · 402 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2021 · 206 citations

Medicine, Genetics, Pharmacotherapy +9

Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

Robert Spiera, Sebastian Unizony, Kenneth J. Warrington et al. · New England Journal of Medicine · 2023 · 113 citations

Life Sciences, Immunology, Pharmacotherapy +17

The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase

Adam I. Marcus, Jun Zhou, Aurora O’Brate et al. · Cancer Research · 2005 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Efficacy of an Inhaled Epidermal Growth Factor Receptor Inhibitor (BIBW 2948 BS) in Chronic Obstructive Pulmonary Disease

Prescott G. Woodruff, Michael W. Wolff, Jens M. Hohlfeld et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 91 citations

Medicine, Pharmacology, Pharmacotherapy +17